Along the same line, Li et al. provided evidence that liraglutide, enhanced the apoptosis of human HCC HepG2 cells in a dose-dependent manner, via increasing the activation of the JNK signaling pathway [61]. Here, MAPK8 is linked to hepatocellular carcinoma.